| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/24/2008 | US20080020053 Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof |
| 01/24/2008 | US20080020052 Vascular Embolus Of Paclitaxel-Sodium Alginate Microsphere And Its Preparation |
| 01/24/2008 | US20080020045 Combination Degradable and Non-Degradable Matrices for Active Agent Delivery |
| 01/24/2008 | US20080020037 Acoustic Pharma-Informatics System |
| 01/24/2008 | US20080020036 Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| 01/24/2008 | US20080020029 Drug Delivery System Using an Immune Response System |
| 01/24/2008 | US20080020024 Fast dissolving orally consumable films |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080020020 Beverage |
| 01/24/2008 | US20080020016 Pharmaceutical compositions for sustained release delivery of peptides |
| 01/24/2008 | US20080020000 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 01/24/2008 | US20080019991 Carrier Conjugates Of Tnf-Peptides |
| 01/24/2008 | US20080019990 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 01/24/2008 | US20080019989 Immunity Adjuvant Containing a Complexed Metal Cation and Vaccine Containing Same |
| 01/24/2008 | US20080019984 Blood-brain barrier targeting antibodies |
| 01/24/2008 | US20080019940 Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| 01/24/2008 | US20080019925 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 01/24/2008 | US20080019917 Compositions Comprising Cells and Magnetic Materials for Targeted Delivery |
| 01/24/2008 | US20080019907 with affinity for an abnormally expressed biological target associated with atherosclerotic plaque; use in diagnosis, surgical guidance |
| 01/24/2008 | US20080017191 Metered dose inhaler |
| 01/24/2008 | DE10121982B4 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation |
| 01/24/2008 | CA2777173A1 Improvement of the bioavailability of active substances having an amidine function in medicaments |
| 01/24/2008 | CA2659521A1 Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| 01/24/2008 | CA2658459A1 Novel amphiphilic cyclodextrin derivatives |
| 01/24/2008 | CA2658395A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/24/2008 | CA2658100A1 High-molecular weight conjugate of combretastatins |
| 01/24/2008 | CA2658082A1 Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same |
| 01/24/2008 | CA2657769A1 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/23/2008 | EP1881327A2 Diagnosis and treatment of malignant neoplasms |
| 01/23/2008 | EP1880744A1 Bisphosphonic acids for the treatment and prevention of osteoporosis |
| 01/23/2008 | EP1880738A1 Medical composition for promotion of skin regeneration |
| 01/23/2008 | EP1880737A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1880732A1 Parathyroid hormone formulation |
| 01/23/2008 | EP1880725A1 Liquid formulation comprising clozapine, quetiapine, a salt of quetiapine and/or olanzapine for oral administration |
| 01/23/2008 | EP1880724A1 Liquid formulation comprising clozapine, quetiapine, a salt of quetiapine and/or olanzapine for oral administration |
| 01/23/2008 | EP1880721A1 Agent for improving circulatory disorder |
| 01/23/2008 | EP1880715A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/23/2008 | EP1879929A1 Synthetic receptor |
| 01/23/2008 | EP1879916A1 Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof |
| 01/23/2008 | EP1879909A1 Stabilizer molecule-enriched albumin solution |
| 01/23/2008 | EP1879622A2 Permeable capsules |
| 01/23/2008 | EP1879616A2 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 01/23/2008 | EP1879603A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 01/23/2008 | EP1879595A2 Compositions and methods for treating hyperproliferative epidermal diseases |
| 01/23/2008 | EP1879568A1 Stable pharmaceutical compositions of platinum (ii) antitumour agents |
| 01/23/2008 | EP1879566A1 Compositions and methods for inhibiting gastric acid secretion |
| 01/23/2008 | EP1879565A2 Topical pharmaceutical formulation containing nimesulide |
| 01/23/2008 | EP1879552A2 Drug delivery compositions and related methods |
| 01/23/2008 | EP1879456A2 Pharmaceutical compositions with synchronized solubilizer release |
| 01/23/2008 | EP1879449A2 Compositions and methods for skin care |
| 01/23/2008 | EP1682113B1 Inhibitor imaging agents |
| 01/23/2008 | EP1545619B1 Solution for ungual application |
| 01/23/2008 | EP1436316B1 Subcellular targeting of therapeutic proteins |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1188057B1 Incorporation and applications of biomolecular interactions within a carrier |
| 01/23/2008 | CN201008658Y Flexible medicament sustained release oral cavity film |
| 01/23/2008 | CN101111522A Plad domain peptides with increased serum half life due to conjugation to domain antibodies |
| 01/23/2008 | CN101111307A Process for producing coated fine particle |
| 01/23/2008 | CN101111306A Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101111268A Conjugates of a polypeptide and an oligosaccharide |
| 01/23/2008 | CN101111267A Stabilized polymeric thiol reagents |
| 01/23/2008 | CN101111258A Emulsified composition for dilution and cancer vaccine composition |
| 01/23/2008 | CN101111251A Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 01/23/2008 | CN101111242A Tablets containing ornithine hydrochloride |
| 01/23/2008 | CN101111231A Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 01/23/2008 | CN101111230A Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 01/23/2008 | CN101108895A Polyglycol ethanal derivant and combo of medicament and the same |
| 01/23/2008 | CN101108252A Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same |
| 01/23/2008 | CN101108251A Preparation of medicinal disintegrating agent with biological enzymatic isolation method |
| 01/23/2008 | CN101108250A Mono- and disaccharide derivatives |
| 01/23/2008 | CN101108246A Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof |
| 01/23/2008 | CN101108224A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108193A Water-solubility rutoside and method of manufacturing the same and oral preparation |
| 01/23/2008 | CN101108188A Novel long circulation alprostadil liposome drug feeding system for injection and method of preparing the same |
| 01/23/2008 | CN101108175A Acid-alkaline buffering composition |
| 01/23/2008 | CN101108172A Oral sticking tablet and method of preparing the same |
| 01/23/2008 | CN101108171A Budesonide intestines sustained release dextromethorphan pellets and method of manufacturing the same |
| 01/23/2008 | CN101108169A Penciclovir freeze dried and method of manufacturing the same |
| 01/23/2008 | CN101108168A Method of manufacturing fulvestrant sustained-release microspheres |
| 01/23/2008 | CN101108167A Method for preparing hydrochloric acid berberine long circulation liposome with ammonium sulphate gradient method-film evaporation method |
| 01/23/2008 | CN101108166A Quantitative nano aerosol and method of manufacturing the same |
| 01/23/2008 | CN101108164A Bcg polyoses nucleic acid intralipid and its cryochem formulated product and use thereof |
| 01/23/2008 | CN101108163A Novel technique of preparing lactic acid ciprofloxacin injection |
| 01/23/2008 | CN100363392C Preparation for transgenic carrier of temperature-sensitive poly isopropyl acrylamide and poly arginine conjugate |
| 01/23/2008 | CN100363056C Medicine for treating upper respiratory tract infection |
| 01/23/2008 | CN100363055C Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 01/23/2008 | CN100363007C Slow release preparation containing larmotriazine |
| 01/23/2008 | CN100362989C Ophthalmic composition containing N-acetyl-cysteine for treatment of dry-eye syndrome |
| 01/23/2008 | CN100362987C Particulate product comprising pantethine |
| 01/23/2008 | CN100362986C Dry powder inhalant composition |
| 01/23/2008 | CN100362984C Prepn. method of matrine magnetic micro-ball |
| 01/22/2008 | US7321059 2,3-diethoxylated propionic acid derivatives, e.g., 20-(7,10,13,16-tetraoxaheptadec-1-yloxy)-2,5,8,11,18-pentaoxahenicosan-21-oic acid; for use in inhalation therapy with propellants for treating respiratory system disorders |
| 01/22/2008 | US7321050 and stilbene oxides; 3,5-dihydroxy-4-isopropylstilbene for example; treating various immune, inflammatory, and autoimmune diseases |
| 01/22/2008 | US7321000 Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320985 Adding a pyridonecarboxylic acid comprising lomefloxacin, norfloxacin, ofloxacin, enoxacin, ciprofloxacin, tosufloxacin, fleroxacin and/or levofloxacin; cinoxacin, sparfloxacin or salt; low temperature; antiinflammatory agents |